Evidence map›Paper›PMID 41700195›Full record

ArticleSisli Etfal Hastanesi tip bulteni2025

Idiopathic Scrotal Elephantiasis: Case Report of a Rare Occurrence.

Busra Guclu, Burak Tunahan Ekincikli, Sabri Ozturk, Kamuran Zeynep Sevim

Abstract readCase Reports
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Busra GucluDepartment of Plastic Reconstructive and Esthetic Surgery, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Burak Tunahan EkincikliDepartment of Plastic Reconstructive and Esthetic Surgery, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Sabri OzturkDepartment of Plastic Reconstructive and Esthetic Surgery, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Kamuran Zeynep SevimDepartment of Plastic Reconstructive and Esthetic Surgery, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic scrotal elephantiasis is a rare yet physically and psychologically debilitating condition characterized by chronic lymphedema of the scrotum. This case report presents an 18-year-old male with progressive scrotal enlargement over seven years. The patient applied to our clinic due to discomfort and occasional discharge. Clinical examination revealed scrotal edema without systemic involvement. Diagnostic imaging excluded other pathologies. Surgical intervention was planned, and 1.2 kg of excess tissue was meticulously excised while preserving the testes and spermatic cords. No complications were observed during the postoperative recovery period that necessitated secondary surgical intervention. Treatment options for idiopathic scrotal elephantiasis range from conservative management, such as elevation, compression therapy, and skin care, to surgical interventions, including vascularized lymph node transfer (VLNT) and lymphaticovenous anastomosis (LVA), in addition to tissue excision. This case report aims to underline the significance of early diagnosis, tailored treatment, and comprehensive postoperative care.

Indexed as

Idiopathic scrotal elephantiasislymphaticovenous anastomosis (LVA)lymphedemascrotal enlargementscrotal lymphedemavascularized lymph node transfer (VLNT)

Identifiers

PMID41700195
PMCPMC12906879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.